UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019

PloS one, 2022-12, Vol.17 (12), p.e0276192-e0276192

2022

Volltextzugriff (PDF)

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020

JAMA network open, 2021-04, Vol.4 (4), p.e216556-e216556

2021

Volltextzugriff (PDF)

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

Clinical infectious diseases, 2020-07, Vol.71 (2), p.304-310

2020

Volltextzugriff (PDF)

Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia

PloS one, 2023-01, Vol.18 (1), p.e0279844-e0279844

2023

Volltextzugriff (PDF)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019

Critical care medicine, 2022-03, Vol.50 (3), p.460

2022

Volltextzugriff (PDF)

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Antimicrobial resistance & infection control, 2018-07, Vol.7 (1), p.79-14, Article 79

2018

Volltextzugriff (PDF)

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

The lancet respiratory medicine, 2022-07, Vol.10 (7), p.689-699

2022

Volltextzugriff (PDF)

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Scientific reports, 2023-03, Vol.13 (1), p.3886-3886, Article 3886

2023

Volltextzugriff (PDF)

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

BMC infectious diseases, 2022-11, Vol.22 (1), p.1-841, Article 841

2022

Volltextzugriff (PDF)

Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail Pharmacy

The Journal of infectious diseases, 2024-03, Vol.229 (3), p.648-659

2024

Volltextzugriff (PDF)

Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019

Infection control and hospital epidemiology, 2022-03, Vol.43 (3), p.277-283

2022

Volltextzugriff (PDF)

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

BMC infectious diseases, 2023-07, Vol.23 (1), p.490-490, Article 490

2023

Volltextzugriff (PDF)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019

BMC infectious diseases, 2022-10, Vol.22 (1), p.1-775, Article 775

2022

Volltextzugriff (PDF)

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP)

PloS one, 2015-07, Vol.10 (7), p.e0131932-e0131932

2015

Volltextzugriff (PDF)

Real-world use of ceftolozane/tazobactam: a systematic literature review

Antimicrobial resistance & infection control, 2021-04, Vol.10 (1), p.68-68, Article 68

2021

Volltextzugriff (PDF)

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study

Lancet Regional Health - Americas (Online), 2022-05, Vol.9, p.100198-100198, Article 100198

2022

Volltextzugriff (PDF)

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

BMC infectious diseases, 2021-02, Vol.21 (1), p.227-227, Article 227

2021

Volltextzugriff (PDF)

Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population

Health and quality of life outcomes, 2023-09, Vol.21 (1), p.1-103, Article 103

2023

Volltextzugriff (PDF)

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system

Scientific reports, 2024-03, Vol.14 (1), p.7485-7485, Article 7485

2024

Volltextzugriff (PDF)

Rate of preventative vaccine use and vaccine beliefs among a commercially insured population

Vaccine, 2020-10, Vol.38 (45), p.7087-7093

2020

Volltextzugriff (PDF)

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?

Pharmacotherapy, 2021-08, Vol.41 (8), p.658-667

2021

Volltextzugriff (PDF)

Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure

Infection control and hospital epidemiology, 2007-02, Vol.28 (2), p.123

2007

Volltextzugriff (PDF)

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

Infectious diseases and therapy, 2020-12, Vol.9 (4), p.953-966

2020

Volltextzugriff (PDF)

Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting

Infectious diseases and therapy, 2020-03, Vol.9 (1), p.107-117

2020

Volltextzugriff (PDF)

Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa

Microbiology spectrum, 2022-10, Vol.10 (5), p.e0233622

2022

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(124)

Sprache

Englisch
(124)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(69)
Humans
(45)
Infectious Diseases
(44)
Sars-Cov-2
(24)
Adult
(23)
Microbiology
(22)
Male
(21)
Covid-19
(20)
Female
(19)
Hospitalization
(18)
Infections
(18)
Pneumonia
(17)
Retrospective Studies
(17)
Severe Acute Respiratory Syndrome Coronavirus 2
(17)
Middle Aged
(16)
Mortality
(16)
Patients
(16)
Immunology
(15)
Aged
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail Pharmacy

Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP)

Real-world use of ceftolozane/tazobactam: a systematic literature review

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system

Rate of preventative vaccine use and vaccine beliefs among a commercially insured population

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?

Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting

Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa

Suchergebnisse filtern